111 related articles for article (PubMed ID: 20048171)
21. [Long-term intravenous infusion of 5-fluorouracil combined with platidiam in local spread of squamous cell carcinoma of the oral cavity].
Gorbunova VA; Liubaev VL; Shatikhin VA; Brzhezovskiĭ VZh; Pustynskiĭ IN
Sov Med; 1989; (5):92-4. PubMed ID: 2675338
[No Abstract] [Full Text] [Related]
22. The predictive value of p53 and p33(ING1b) in patients with Dukes'C colorectal cancer.
Ahmed IA; Kelly SB; Anderson JJ; Angus B; Challen C; Lunec J
Colorectal Dis; 2008 May; 10(4):344-51. PubMed ID: 17949449
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of anticancer drug effects in vivo by serial DNA flow cytometry of oral carcinomas treated by intra-arterial 5-fluorouracil/cisplatin induction chemotherapy.
Hemmer J; Kreidler J; Kraft K; Schön E
Anticancer Res; 1994; 14(5B):2077-83. PubMed ID: 7840503
[TBL] [Abstract][Full Text] [Related]
24. Influence of chemotherapy on endosteal implant survival and success in oral cancer patients.
Kovács AF
Int J Oral Maxillofac Surg; 2001 Apr; 30(2):144-7. PubMed ID: 11405450
[TBL] [Abstract][Full Text] [Related]
25. Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity.
Kirita T; Ohgi K; Tsuyuki M; Kamikaido N; Yamamoto K; Sugimura M
J Surg Oncol; 1996 Dec; 63(4):240-8. PubMed ID: 8982368
[TBL] [Abstract][Full Text] [Related]
26. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G
Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541
[TBL] [Abstract][Full Text] [Related]
27. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
28. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
29. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
30. Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy.
Moreira LF; Naomoto Y; Hamada M; Kamikawa Y; Orita K
Anticancer Res; 1995; 15(2):639-44. PubMed ID: 7539243
[TBL] [Abstract][Full Text] [Related]
31. Post-operative chemotherapy improves disease-free survival, but not overall survival in people with oesophageal squamous cell carcinoma.
Leonard GD; Reilly EM
Cancer Treat Rev; 2004 Aug; 30(5):473-7. PubMed ID: 15245779
[No Abstract] [Full Text] [Related]
32. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
35. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution.
Okura M; Hiranuma T; Adachi T; Ogura T; Aikawa T; Yoshioka H; Hayashido Y; Kogo M; Matsuya T
Cancer; 1998 Mar; 82(5):804-15. PubMed ID: 9486567
[TBL] [Abstract][Full Text] [Related]
36. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
37. [Neoadjuvant treatment of operable esophageal cancers].
Azria D; Ychou M; Senesse P; Dubois JB
Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
[No Abstract] [Full Text] [Related]
38. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
39. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
[TBL] [Abstract][Full Text] [Related]
40. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
Lavertu P; Adelstein DJ; Myles J; Secic M
Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]